Aurinia Pharmaceuticals Inc. (AUPH) Financial Statements (2026 and earlier)

Company Profile

Business Address #140, 14315 - 118 AVENUE
EDMONTON, AB T5L 4S6
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments397,944351,508315,045312,586358,439348,235
Cash and cash equivalent80,16072,88952,91466,11383,39636,630
Short-term investments317,784278,619262,131246,473275,043311,605
Inventory, net of allowances, customer advances and progress billings45,69044,79346,50346,19539,22838,714
Inventory45,69044,79346,50346,19539,22838,714
Prepaid expense4,0045,4334,6914,3875,5741,896
Deposits current assets      4,189
Other current assets1,0803016657811,1292,700
Other undisclosed current assets43,24936,70242,06641,81342,22644,725
Total current assets:491,967438,737408,970405,762446,596440,459
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization73,86578,81383,19587,57792,07296,459
Operating lease, right-of-use asset3,5963,7183,8373,9544,0684,179
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,1112,2662,4212,5762,7312,887
Intangible asset, including goodwill, after accumulated amortization3,7613,9014,0464,1584,3554,509
Intangible asset, excluding goodwill, after accumulated amortization3,7613,9014,0464,1584,3554,509
Deferred income tax assets176,194     
Other noncurrent assets939393823823868
Total noncurrent assets:259,62088,79193,59299,088104,049108,902
TOTAL ASSETS:751,587527,528502,562504,850550,645549,361
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:66,62149,53649,70442,35370,15856,770
Accounts payable3,3132,2143,3124,2205,1878,878
Accrued liabilities66,62149,53649,70442,35364,97119,859
Other undisclosed accounts payable and accrued liabilities(3,313)(2,214)(3,312)(4,220) 28,033
Deferred revenue3,7204,6025,4994,59411,0024,304
Debt16,52316,30916,16714,50814,04614,927
Other liabilities2,4802,5022,5371,6951,5311,590
Other undisclosed current liabilities4,3803,2714,3595,2561,0261,018
Total current liabilities:93,72476,22078,26668,40697,76378,609
Noncurrent Liabilities
Long-term debt and lease obligation52,32255,72759,28256,82858,55465,955
Finance lease, liability52,32255,72759,28256,82858,55465,955
Liabilities, other than long-term debt17,54829,76829,68329,38816,85016,795
Deferred revenue12,64812,24912,34912,450  
Other liabilities 12,40012,00011,40011,10710,844
Operating lease, liability4,9005,1195,3345,5385,7435,951
Other undisclosed noncurrent liabilities6,662423038  
Total noncurrent liabilities:76,53285,53788,99586,25475,40482,750
Total liabilities:170,256161,757167,261154,660173,167161,359
Equity
Equity, attributable to parent, including:581,331365,771335,301350,190377,478388,002
Additional paid in capital111,263109,885105,337100,979126,999119,773
Accumulated other comprehensive loss(599)(749)(905)(825)(647)(385)
Accumulated deficit(649,368)(860,162)(891,713)(913,226)(936,570)(937,999)
Other undisclosed equity, attributable to parent1,120,0351,116,7971,122,5821,163,2621,187,6961,206,613
Total equity:581,331365,771335,301350,190377,478388,002
TOTAL LIABILITIES AND EQUITY:751,587527,528502,562504,850550,645549,361

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Revenues77,11473,46870,00862,46559,86767,771
Cost of revenue(8,799)(8,177)(7,115)(8,574)(5,552)(6,035)
Gross profit:68,31565,29162,89353,89154,31561,736
Operating expenses94,149(34,617)(33,450)(26,082)147,674(45,414)
Other operating income (expense), net5,074(929)(9,246)(4,429)4,506(4,574)
Other undisclosed operating loss (134,299) (114)(1,533)(208,164) 
Operating income (loss):33,23929,74520,08321,847(1,669)11,748
Nonoperating income
(Investment Income, Nonoperating)		3,4983,3163,1903,5693,9884,267
Interest and debt expense(1,047)(1,099)(1,117)(1,067)(1,146)(1,208)
Income from continuing operations before income taxes:35,69031,96222,15624,3491,17314,807
Income tax expense (benefit)175,104(411)(643)(1,005)256(457)
Net income available to common stockholders, diluted:210,79431,55121,51323,3441,42914,350

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Net income:210,79431,55121,51323,3441,42914,350
Comprehensive income:210,79431,55121,51323,3441,42914,350
Other undisclosed comprehensive income (loss), net of tax, attributable to parent150156(80)(178)(262)474
Comprehensive income, net of tax, attributable to parent:210,94431,70721,43323,1661,16714,824

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: